Gain Therapeutics reports third quarter 2022 financial results and business update

Delvitech Expands Global Presence with New India Office

Artificialy, “Company of the Future” in Tages Anzeiger

BigOmics announces pre-Series A financing round

Press conference for announcement of re-financing of additional CHF 5Mio to TiVentures by BancaStato Cantone Ticino

Lorenzo Leoni, partecipates to Swiss TV Program: “Eccelenze Ticinesi”

FEMTOprint and Millimeter-sized particle sensor commissioned by CEA-LETI.

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a biotechnology company focused on redefining drug discovery by identifying and optimizing allosteric binding sites that have never before been targeted

Delvitech and Velankani announce a new partnership

Delvitech and Velankani have signed a production partnership agreement. The Indian group will be in charge of manufacturing the whole machine structure, except for the Optical Head, which will continue to be produced in Switzerland.

Gain Therapeutics To Present At The Jefferies Virtual Healthcare Conference

Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a biotechnology company focused on redefining drug discovery by identifying and optimizing allosteric binding sites that have never before been targeted

SmartBone ® On Demand™ got the MDR certification!

After months of hard-working that engaged the whole IBI’s team our custom-made service obtained the MDR certification by Notified Body BSI.